Skip to main content
All lobbying filings

STEALTH BIOTHERAPEUTICS INC.

Lobbying for STEALTH BIOTHERAPEUTICS INC. · Developing therapies to treat mitochondrial dysfunction.

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$110,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

H.R. 7384/S. 4583, the Creating Hope Reauthorization Act of 2024 (118th Congress) H.R. 1509/S. 752 the Accelerating Kids Access to Care Act H.R. 1262/S. 932 - Give Kids a Chance Act of 2025 General discussions about ultra-rare disease drug development General discussions about regulatory reform, including scientific-focused drug development meetings H.R. 1092/S. 526, the BENEFIT Act (118th Congress) General discussions about mitochondrial diseases H.R. 1532/S. 822, the Scientific EXPERT Act of 2025 General discussions about ultra-rare diseases FDA Rare Disease Innovation Hub ORPHAN Cures Act (H.R. 946 / S. 1862) [part of One, Big, Beautiful Bill Act (H.R 1)] Fiscal Year 2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R. 4121 / S. 2256)

 Bills named in this filing 15
  • H.R. 7384
    Creating Hope Reauthorization Act of 2024
  • S. 4583
    Creating Hope Reauthorization Act of 2024
  • H.R. 1509
    Accelerating Kids’ Access to Care Act of 2025
  • S. 752
    Accelerating Kids’ Access to Care Act
  • H.R. 1262
    Mikaela Naylon Give Kids a Chance Act
  • S. 932
    Give Kids a Chance Act of 2025
  • H.R. 1092
    BENEFIT Act of 2023
  • S. 526
    Pharmacy Benefit Manager Transparency Act of 2025
  • H.R. 1532
    Scientific EXPERT Act of 2025
  • S. 822
    Scientific EXPERT Act of 2025
  • H.R. 946
    ORPHAN Cures Act
  • S. 1862
    ORPHAN Cures Act
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 4121
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
  • S. 2256
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem